专题：Adenosine and Purinergic Signaling

This cluster of papers focuses on the molecular physiology and pharmacology of purinergic signalling, including the role of adenosine receptors, P2X receptors, and nucleotide signalling in immune suppression, inflammation, neuroprotection, and the tumor microenvironment. It explores the potential therapeutic targets related to purinergic signalling.
最新文献
Glial Activation, Neuroinflammation, and Loss of Neuroprotection in Chronic Pain: Cellular Mechanisms and Emerging Therapeutic Strategies

article Full Text OpenAlex

Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial

article Full Text OpenAlex

Perineural invasion as a neuro−immune niche in head and neck cancer: mechanisms of immune evasion and therapeutic implications

article Full Text OpenAlex

Aberrant adenosine A2A receptor signaling in the choroid plexus drives CSF hypersecretion and ventriculomegaly in hydrocephalus

article Full Text OpenAlex

Reversing adenosine-mediated immunosuppression in triple-negative breast cancer by synergistic chemo-immunotherapy via stimuli-responsive nanomedicines

article Full Text OpenAlex

Celecoxib in oncology: targeting the COX-2/PGE2 axis to reprogram the tumor immune microenvironment and enhance multimodal therapy

review Full Text OpenAlex

Divergent viral phosphodiesterases for immune signaling evasion

article Full Text OpenAlex

Effects of caffeine on neuroinflammation in anxiety and depression: a systematic review of rodent studies

article Full Text OpenAlex

Adenosine signalling drives antidepressant actions of ketamine and ECT

article Full Text OpenAlex

CD39 and CD73: biological functions, diseases and therapy

review Full Text OpenAlex

近5年高被引文献
Nucleotide metabolism: a pan-cancer metabolic dependency

review Full Text OpenAlex 404 FWCI65.8887

Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials

review Full Text OpenAlex 317 FWCI27.1795

Targeting inflammation to treat diabetic kidney disease: the road to 2030

review Full Text OpenAlex 311 FWCI43.3517

CD39/CD73/A2AR pathway and cancer immunotherapy

review Full Text OpenAlex 302 FWCI79.2334

Parkinson’s disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes

article Full Text OpenAlex 228 FWCI31.3512

Biomarker of Neuroinflammation in Parkinson’s Disease

review Full Text OpenAlex 221 FWCI25.5418

Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation

article Full Text OpenAlex 220 FWCI33.3985

Adenosine and Adenine Nucleotides As Regulators of Cellular Function

book Full Text OpenAlex 199 FWCI3.5385

ER-Targeting Cyanine Dye as an NIR Photoinducer to Efficiently Trigger Photoimmunogenic Cancer Cell Death

article Full Text OpenAlex 191 FWCI14.7461

ROS-dependent S-palmitoylation activates cleaved and intact gasdermin D

article Full Text OpenAlex 191 FWCI46.1798